Consecutive thrombelastography clot strength profiles in patients with severe sepsis and their association with 28-day mortality: A prospective study

Journal of Critical Care

Volumn 28, Issue 3, 2013, Pages 317.e1-317.e11

  Ostrowski, Sisse R ^a   Windeløv, Nis A ^b   Ibsen, Michael ^b   Haase, Nicolai ^b   Perner, Anders ^b   Johansson, Pär I ^a,c  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Rigshospitalet   (Denmark)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Coagulopathy; Disseminated intravascular coagulation (DIC); Mortality; Platelet function; Rotation thromboelastometry (ROTEM); Sepsis; Thrombelastography

Indexed keywords

FIBRINOGEN;

ADULT; ARTICLE; BLOOD CLOTTING TEST; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DISSEMINATED INTRAVASCULAR CLOTTING; FEMALE; HOSPITAL DISCHARGE; HUMAN; HYPERCOAGULABILITY; HYPOCOAGULABILITY; INFECTION; INTENSIVE CARE UNIT; LENGTH OF STAY; MALE; MORTALITY; SCORING SYSTEM; SEPSIS; SEVERE SEPSIS; SURVIVAL TIME; THROMBOCYTE COUNT; THROMBOELASTOGRAPHY;

AGED; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; ORGAN DYSFUNCTION SCORES; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SEPSIS; STATISTICS, NONPARAMETRIC; THROMBELASTOGRAPHY;

EID: 84876832042     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2012.09.003     Document Type: Article

References (35)

1. Schouten M., Wiersinga W.J., Levi M., et al. Inflammation, endothelium, and coagulation in sepsis. J Leukoc Biol 2008, 83:536-545.
2. Faust S.N., Levin M., Harrison O.B., et al. Dysfunction of endothelial protein C activation in severe meningococcal sepsis. N Engl J Med 2001, 345:408-416.
3. Collins P.W., Macchiavello L.I., Lewis S.J., et al. Global tests of haemostasis in critically ill patients with severe sepsis syndrome compared to controls. Br J Haematol 2006, 135:220-227.
4. Gonano C., Sitzwohl C., Meitner E., et al. Four-day antithrombin therapy does not seem to attenuate hypercoagulability in patients suffering from sepsis. Crit Care 2006, 10:R160.
5. Daudel F., Kessler U., Folly H., et al. Thromboelastometry for the assessment of coagulation abnormalities in early and established adult sepsis: a prospective cohort study. Crit Care 2009, 13:R42.
6. Sivula M., Pettila V., Niemi T.T., et al. Thromboelastometry in patients with severe sepsis and disseminated intravascular coagulation. Blood Coagul Fibrinolysis 2009, 20:419-426.
7. Johansson P.I., Stensballe J., Vindelov N., et al. Hypocoagulability, as evaluated by thrombelastography, at admission to the ICU is associated with increased 30-day mortality. Blood Coagul Fibrinolysis 2010, 21:168-174.
8. Sharma P., Saxena R. A novel thromboelastographic score to identify overt disseminated intravascular coagulation resulting in a hypocoagulable state. Am J Clin Pathol 2010, 134:97-102.
9. Adamzik M., Langemeier T., Frey U.H., et al. Comparison of thrombelastometry with SAPS II and SOFA scores for the prediction of 30-day survival: a cohort study. Shock 2011, 35:339-342.
10. Adamzik M., Eggmann M., Frey U.H., et al. Comparison of thromboelastometry with procalcitonin, interleukin 6, and C-reactive protein as diagnostic tests for severe sepsis in critically ill adults. Crit Care 2010, 14:R178.
11. Spiel A.O., Mayr F.B., Firbas C., et al. Validation of rotation thrombelastography in a model of systemic activation of fibrinolysis and coagulation in humans. J Thromb Haemost 2006, 4:411-416.
12. Velik-Salchner C., Streif W., Innerhofer P., et al. Endotoxinemia-induced changes in coagulation as measured by rotation thrombelastometry technique and conventional laboratory tests: results of a pilot study on pigs. Blood Coagul Fibrinolysis 2009, 20:41-46.
13. Eralp O., Yilmaz Z., Failing K., et al. Effect of experimental endotoxemia on thrombelastography parameters, secondary and tertiary hemostasis in dogs. J Vet Intern Med 2011, 25:524-531.
14. Tsai H.J., Tsao C.M., Liao M.H., et al. Application of thrombelastography in liver injury induced by endotoxin in rat. Blood Coagul Fibrinolysis 2012, 23:118-126.
15. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992, 20:864-874.
16. Taylor F.B., Toh C.H., Hoots W.K., et al. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 2001, 86:1327-1330.
17. Kienast J., Juers M., Wiedermann C.J., et al. Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation. J Thromb Haemost 2006, 4:90-97.
18. Bolliger D., Seeberger M.D., Tanaka K.A. Principles and practice of thromboelastography in clinical coagulation management and transfusion practice. Transfus Med Rev 2012, 26:1-13.
19. Johansson P.I., Stissing T., Bochsen L., et al. Thrombelastography and tromboelastometry in assessing coagulopathy in trauma. Scand J Trauma Resusc Emerg Med 2009, 17:45.
20. Ostrowski S.R., Sorensen A.M., Larsen C.F., et al. Thrombelastography and biomarker profiles in acute coagulopathy of trauma: a Prospective study. Scand J Trauma Resusc Emerg Med 2011, 19:64.
21. Johansson P.I., Bochsen L., Andersen S., et al. Investigation of the effect of kaolin and tissue factor-activated citrated whole blood, on clot forming variables, as evaluated by thromboelastography. Transfusion 2008, 48:2377-2383.
22. Xing K., Murthy S., Liles W.C., et al. Clinical utility of biomarkers of endothelial activation in sepsis-a systematic review. Crit Care 2012, 16:R7.
23. Johansson P.I., Ostrowski S.R. Acute coagulopathy of trauma: balancing progressive catecholamine induced endothelial activation and damage by fluid phase anticoagulation. Med Hypotheses 2010, 75:564-567.
24. Leslie M. Cell biology. Beyond clotting: the powers of platelets. Science 2010, 328:562-564.
25. Semple J.W., Italiano J.E., Freedman J. Platelets and the immune continuum. Nat Rev Immunol 2011, 11:264-274.
26. Li Z., Yang F., Dunn S., et al. Platelets as immune mediators: their role in host defense responses and sepsis. Thromb Res 2011, 127:184-188.
27. Ostrowski S.R., Johansson P.I. Rethinking platelet function: thrombocytopenia induced immunodeficiency in critical illness. Med Hypotheses 2011, 77:798-802.
28. Yaguchi A., Lobo F.L., Vincent J.L., et al. Platelet function in sepsis. J Thromb Haemost 2004, 2:2096-2102.
29. Cowan D.H., Bowman L.S., Fratianne R.B., et al. Platelet aggregation as a sign of septicemia in thermal injury. A prospective study. JAMA 1976, 235:1230-1234.
30. Alt E., mann-Vesti B.R., Madl C., et al. Platelet aggregation and blood rheology in severe sepsis/septic shock: relation to the Sepsis-related Organ Failure Assessment (SOFA) score. Clin Hemorheol Microcirc 2004, 30:107-115.
31. Woth G., Varga A., Ghosh S., et al. Platelet aggregation in severe sepsis. J Thromb Thrombolysis 2011, 31:6-12.
32. Johansson P.I., Stensballe J., Rasmussen L.S., et al. A high admission syndecan-1 level, a marker of endothelial glycocalyx degradation, is associated with inflammation, protein C depletion, fibrinolysis, and increased mortality in trauma patients. Ann Surg 2011, 254:194-200.
33. Johansson P.I., Stensballe J., Rasmussen L.S., et al. High circulating adrenaline levels at admission predict increased mortality after trauma. J Trauma Acute Care Surg 2012, 72:428-436.
34. Ostrowski S.R., Sørensen A.M., Windeløv N.A., et al. High levels of soluble VEGF receptor 1 early after trauma are associated with shock, sympathoadrenal activation, glycocalyx degradation and inflammation. Scand J Trauma Resusc Emerg Med 2012, 20:27.
35. Johansson P.I., Sørensen A.M., Perner A., et al. High sCD40L levels early after trauma are associated with enhanced shock, sympathoadrenal activation, tissue and endothelial damage, coagulopathy and mortality. J Thromb Haemost 2011, 10:207-216.